Pharmacology, Toxicology and Pharmaceutical Science
Neoplasm
100%
Mebendazole
54%
Clostridium novyi
38%
Mouse
38%
Malignant Neoplasm
37%
Glioblastoma
27%
Medulloblastoma
26%
Clinical Trial
21%
Brain Tumor
20%
Phosphotransferase
20%
Tumor Model
17%
Cytokine Release Syndrome
15%
Anaplastic Large Cell Lymphoma
15%
Hypoxia
14%
Disease
14%
Malignant Peripheral Nerve Sheath Tumor
12%
Infection
12%
Brain Cancer
12%
Coronavirinae
11%
Nucleophosmin
10%
Glioma
10%
Catecholamine
10%
Antiapoptotic
10%
Phosphatidylinositol 3 Kinase
10%
Pharmacotherapy
10%
Anaplastic Lymphoma Kinase
10%
Neurofibromatosis Type 1
9%
Anthelmintic Agent
8%
Retinoic Acid
7%
Nanoparticle
7%
Axicabtagene Ciloleucel
7%
Leporidae
7%
Neurofibromin
7%
Pemetrexed
7%
Antibiotics
7%
Disulfiram
7%
Syndrome
7%
Adeno Associated Virus
7%
Replacement Therapy
7%
Redox Effector Factor 1
7%
Drug Discovery
7%
Repurposing
7%
Growth Factor Receptor Bound Protein 10
7%
Large Cell Lymphoma
7%
Colon Cancer
7%
Nuclear Protein
7%
Tumor Microenvironment
7%
Brain Abscess
7%
Cytokine Storm
7%
Chimeric Protein
7%
Medicine and Dentistry
Magnetic Resonance Imaging
46%
Neoplasm
45%
Mebendazole
38%
Chemical Exchange Saturation Transfer
29%
Malignant Peripheral Nerve Sheath Tumor
28%
Malignant Neoplasm
23%
Ganglioglioma
19%
Clinical Trial
17%
Neurofibromatosis Type I
16%
Medulloblastoma
16%
Dextran
15%
Cancer
11%
Infection
11%
COVID-19
11%
Contrast Medium
10%
Glioblastoma
9%
In Vitro
9%
Signal Transduction
9%
Chemotherapy
8%
Brain Cancer
8%
Anthelmintic
8%
Real-Time MRI
7%
Adeno-Associated Virus
7%
Tumor Seeding
7%
Blood Vessel Permeability
7%
Phosphoinositide 3-Kinase
7%
Nucleophosmin
7%
Antiapoptotic
7%
Neurofibromin 1
7%
Podocalyxin
7%
Redox Effector Factor 1
7%
Needle Biopsy
7%
Large-Cell Lymphoma
7%
Deuterium Oxide
7%
Temozolomide
7%
Peripheral Nerve
7%
Antibiotic Therapy
7%
Disulfiram
7%
Gene Replacement Therapy
7%
Imaging Agent
7%
Neuromonitoring
7%
Cytokine Storm
7%
Cancer Stem Cell
7%
Nuclear Protein
7%
Lower Respiratory Tract Infection
7%
Combination Therapy
7%
Gelatin
7%
Anaplastic Lymphoma Kinase
7%
Anti-Inflammatory Drug
7%
Brain Abscess
7%
Keyphrases
Anaplastic Lymphoma Kinase
31%
Nucleophosmin 1 (NPM1)
27%
Anaplastic Large Cell Lymphoma
27%
Tumor
23%
Medulloblastoma
23%
Mebendazole
23%
Malignant Peripheral Nerve Sheath Tumor (MPNST)
20%
Cancer Therapy
17%
Neurofibromatosis Type 1 (NF-1)
16%
Lymphoma
16%
Clostridium Novyi
15%
BCR-ABL
15%
Mitogenicity
15%
Therapeutic Target
15%
In Cancer
15%
Glioblastoma multiforme
15%
Phosphorylation
12%
Therapeutic Development
11%
Oncogene
10%
Clinical Trials
10%
Malignancy
10%
Tumor Hypoxia
9%
Glioblastoma
9%
Apoptosis
9%
Tyrosine
9%
Neurofibromatosis Type I
9%
Phospholipase C
8%
Phosphoinositide 3-kinase (PI3K)
8%
Brain Cancer
8%
Tumor Model
7%
E3 Ligase
7%
Real-time MRI
7%
In Vitro Tumor Models
7%
Transforming Growth Factor-β
7%
Transcriptional Regulator
7%
Imatinib
7%
Neurofibromin 1
7%
Contrast Media
7%
Combination Therapy
7%
Preventive Effect
7%
Cisplatin
7%
Neutrophil Depletion
7%
Non-steroidal Anti-inflammatory Drugs (NSAIDs)
7%
Phase 1 Clinical Trial
7%
Disulfiram
7%
Nuclear Proteins
7%
GTPase-activating Protein
7%
Investigational New Drug
7%
GRB10
7%
Adenovirus
7%